Literature DB >> 24096433

Chest X-ray in the follow-up of renal cell carcinoma.

B H J Doornweerd1, I J de Jong, L M Bergman, H J K Ananias.   

Abstract

PURPOSE: To evaluate the value of chest X-ray in the follow-up of surgically treated T1-3N0M0 renal cell carcinoma.
METHODS: We performed retrospective analysis of patients that underwent surgical treatment of a localized renal cell carcinoma (T1-3N0M0) between January 1993 and July 2010. Data on frequency and results of performed chest X-rays were collected from patients' records.
RESULTS: In 17.5 years, 249 patients with a T1-3N0M0 renal cell carcinoma underwent a radical or partial nephrectomy. In 221 patients, 823 chest X-rays were performed during a median follow-up of 3.3 years (range 0.5-17 years). In 19 patients, a pulmonary recurrence occurred, of which 10 were not detected by the regular follow-up. Of the 9 patients that were diagnosed with a pulmonary recurrence with a chest X-ray during follow-up, 7 were asymptomatic at the time of diagnosis, and the chest X-ray has led to the detection; 0.85 % of the performed chest X-rays (7/823) have led to the detection of asymptomatic lung metastases.
CONCLUSIONS: Due to the low yield of chest X-ray for detection of asymptomatic pulmonary recurrences, it has very low clinical value in the follow-up after nephrectomy for T1-3N0M0 renal cell carcinoma.

Entities:  

Mesh:

Year:  2013        PMID: 24096433     DOI: 10.1007/s00345-013-1176-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  23 in total

1.  Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

Authors:  Hans-Stefan Hofmann; Heinz Neef; Katharina Krohe; Petko Andreev; Rolf-Edgar Silber
Journal:  Eur Urol       Date:  2005-03-20       Impact factor: 20.096

2.  Preoperative nomogram predicting 12-year probability of metastatic renal cancer.

Authors:  Ganesh V Raj; R Houston Thompson; Bradley C Leibovich; Michael L Blute; Paul Russo; Michael W Kattan
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

Review 3.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

4.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.

Authors:  A F Fergany; K S Hafez; A C Novick
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

5.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Authors:  John S Lam; Oleg Shvarts; John T Leppert; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

Review 6.  Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

Authors:  Maxine Sun; Shahrokh F Shariat; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Richard Zigeuner; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-06-30       Impact factor: 20.096

7.  A new protocol for the followup of renal cell carcinoma based on pathological stage.

Authors:  D S Sandock; A D Seftel; M I Resnick
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

8.  American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.

Authors:  James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

9.  Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy.

Authors:  R A Graham; S Wang; P J Catalano; D G Haller
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Chest X-ray survey in the follow-up of breast cancer patients.

Authors:  S Ciatto; P Pacini; C Andreoli; S Cecchini; A Iossa; G Grazzini; F Buranelli; T Campa; A Costa; A Magni
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

View more
  6 in total

1.  A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

Authors:  Christian Beisland; Gigja Guðbrandsdottir; Lars A R Reisæter; Leif Bostad; Karin M Hjelle
Journal:  World J Urol       Date:  2016-02-27       Impact factor: 4.226

2.  Impact of routine imaging in the diagnosis of recurrence for patients with localized and locally advanced renal tumor treated with nephrectomy.

Authors:  Baptiste Gires; Zine-Eddine Khene; Pierre Bigot; Quentin Alimi; Benoit Peyronnet; Grégory Verhoest; Andrea Manunta; Karim Bensalah; Romain Mathieu
Journal:  World J Urol       Date:  2019-03-20       Impact factor: 4.226

3.  Canadian Urological Association guideline: Management of small renal masses - Full-text.

Authors:  Patrick O Richard; Philippe D Violette; Bimal Bhindi; Rodney H Breau; Wassim Kassouf; Luke T Lavallée; Michael Jewett; John R Kachura; Anil Kapoor; Maxine Noel-Lamy; Michael Ordon; Stephen E Pautler; Frédéric Pouliot; Alan I So; Ricardo A Rendon; Simon Tanguay; Christine Collins; Maryam Kandi; Bobby Shayegan; Andrew Weller; Antonio Finelli; Andrea Kokorovic; Jay Nayak
Journal:  Can Urol Assoc J       Date:  2022-02       Impact factor: 1.862

Review 4.  Follow-up after curative treatment of localised renal cell carcinoma.

Authors:  Saeed Dabestani; Lorenzo Marconi; Teele Kuusk; Axel Bex
Journal:  World J Urol       Date:  2018-05-16       Impact factor: 4.226

5.  Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound?

Authors:  Mark Quinlan; Gavin Wei; Niall Davis; Cedric Poyet; Marlon Perera; Damien Bolton; Nathan Lawrentschuk
Journal:  Curr Urol       Date:  2019-09-10

6.  Available active surveillance follow-up protocols for small renal mass: a systematic review.

Authors:  Giacomo Rebez; Nicola Pavan; M Carmen Mir
Journal:  World J Urol       Date:  2021-01-16       Impact factor: 4.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.